Skip to main content
Top menu
News & Media
Contact Us
Main navigation
Our Team
Clinical Trials
Hematologic Cancers
Enitociclib
VIP943
Solid Tumors
VIP236
Pipeline
Publications
Partners
Investors
Overview
Stock Information
Stock Quote & Chart
News Releases
Corporate Overview & Events
Corporate Overview
Investor Calendar
SEC Filings & Financials
SEC Filings
Corporate Governance
Governance Highlights
Board of Directors
Committee Composition
Investor Resources
Email Alerts
Contact IR
Culture & Careers
News & Media
Contact Us
News & Media
The 2024 PharmaVoice 100 | PharmaVoice
October 8, 2024
Pharmaphorum: Disrupting Cancer Cell Growth and the Treatment Paradigm
August 2024
Ellevate Podcast
April 2024
The Medicine Maker 2024 Power List
April 2024
Fierce Biotech: AACR: Biotechs emerge frostbitten from 'nuclear winter,' ready to show why they fought for survival
April 18, 2024
Market RECISTs Vincerx’s ‘amazing’ phase I cancer data
April 8, 2024
Early tests approach for Vincerx’s conjugate revolution
March 13, 2024
